why Eledon Pharmaceuticals Inc [ELDN] is a Good Choice for Investors After New Price Target of $13.88
Eledon Pharmaceuticals Inc [NASDAQ: ELDN] loss -4.66% or -0.21 points to close at $4.30 with a heavy trading volume of 258620 shares. The daily chart for ELDN points out that the company has recorded 76.95% gains over the past six months. If we look at